STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia

NCT00006052 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis